CSM Advisors LLC Boosts Eli Lilly Holdings by 918.9%

The investment firm now owns $8.37 million in shares of the pharmaceutical giant.

Mar. 16, 2026 at 9:09am

Got story updates? Submit your updates here. ›

CSM Advisors LLC significantly increased its stake in Eli Lilly and Company (NYSE:LLY) during the third quarter, according to a recent SEC filing. The firm boosted its holdings in Lilly by 918.9%, now owning 10,974 shares worth $8.37 million.

Why it matters

Eli Lilly is one of the world's largest pharmaceutical companies, known for blockbuster drugs like Trulicity and Mounjaro. This substantial investment by CSM Advisors suggests the firm sees strong growth potential in Lilly's pipeline and business outlook.

The details

According to the filing, CSM Advisors purchased an additional 9,897 shares of Eli Lilly in the third quarter, bringing its total holdings to 10,974 shares. This represents a nearly 10-fold increase in the firm's position compared to the prior quarter.

  • CSM Advisors filed the disclosure with the SEC in the third quarter of 2026.

The players

CSM Advisors LLC

An investment management firm that oversees over $8 billion in client assets.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana.

Got photos? Submit your photos here. ›

The takeaway

This significant increase in Eli Lilly holdings by CSM Advisors underscores the firm's confidence in Lilly's long-term growth prospects as a leading pharmaceutical innovator.